甘李药业(603087.SH)：甘精胰岛素注射液及其预填充注射笔获得埃塞俄比亚药品注册批件

Core Viewpoint - Gan Li Pharmaceutical has received approval from the Ethiopian Food and Drug Authority for the registration of Glargine Insulin Injection and Glargine Insulin Injection Pre-filled Pen, indicating a significant step in expanding its product offerings in the Ethiopian market [1] Company Summary - The approved products include Glargine Insulin Injection and its pre-filled pen, with registration numbers 11865/13208/NMR/2025 and 11864/13210/NMR/2025 respectively [1] - Glargine Insulin is a long-acting insulin that requires subcutaneous injection once daily, providing a blood sugar-lowering effect that lasts for 24 hours [1] - The characteristics of Glargine Insulin include a long duration of action, stable blood concentration without peaks, and smooth glucose control [1]